Tranexamic acid is effective in reducing blood loss, while maintaining safety, in THA .
Do we really need tranexamic acid in total hip arthroplasty? A meta-analysis of nineteen randomized controlled trials
Arch Orthop Trauma Surg. 2013 Jul;133(7):1017-27. doi: 10.1007/s00402-013-1761-2. Epub 2013 Apr 2519 randomized control trials (n=1,030) evaluating the use of tranexamic acid (TXA) in total hip arthroplasty (THA) procedures were included in this review to investigate the effectiveness of this treatment in the reduction of blood loss. Results indicated that the use of TXA in THA yielded significantly improved total blood loss, intraoperative blood loss volume, postoperative blood loss, "hidden" blood loss, changes in haemoglobin and hematocrit, as well as the number of patients requiring an allogenic blood transfusion. TXA use in THA did not affect the number of blood units transfused per patient, the incidence of deep vein thrombosis, the incidence of developing a pulmonary embolism , or the duration of hospital stay. Lastly, there was a positive correlation between dosage of TXA and total blood loss.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
